Akebia Therapeutics Stock News

Northern Trust Corp grew its holdings in shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA) by 2.1% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,690,808 shares of the biopharmaceutical companys stock after acquiring an additional 34,569 shares during the quarter. Northern Trust Corp owned 0.97% []

Akebia Therapeutics (NASDAQ:AKBA) had its price target boosted by HC Wainwright from $6.00 to $10.00 in a research note issued to investors on Thursday, Analyst Price Targets reports. The brokerage currently has a buy rating on the biopharmaceutical companys stock. Separately, Zacks Investment Research cut shares of Akebia Therapeutics from a buy rating to a []

Marshall Wace LLP acquired a new stake in Akebia Therapeutics, Inc. (NASDAQ:AKBA) in the 2nd quarter, Holdings Channel reports. The institutional investor acquired 4,109,589 shares of the biopharmaceutical companys stock, valued at approximately $15,575,000. A number of other hedge funds also recently made changes to their positions in AKBA. Walleye Capital LLC raised its holdings []

Akebia Therapeutics, Inc. (AKBA) CEO John Butler on Q3 2021 Results - Earnings Call Transcript

Unwilling to wait for catalysts, some investors threw these small-cap stocks into the garbage bin. But that doesn't mean they won't succeed.

CAMBRIDGE, Mass. , Sept. 1, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today

Akebia Therapeutics, Inc. (AKBA) CEO John Butler on Q2 2021 Results - Earnings Call Transcript

Akebia Therapeutics (AKBA) delivered earnings and revenue surprises of -70.00% and -11.93%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Are these biotech penny stocks worth investing in or not? The post 3 Hot Biotech Penny Stocks to Watch With High Volume in 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | Pen

Akebia Therapeutics (AKBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

LOS ANGELES--(BUSINESS WIRE)---- $AKBA #AKBA--INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Akebia Therapeutics, Inc.

Reddit penny stocks are in focus right now; here's 3 to watch The post These Penny Stocks Are Frequently Talked About on Reddit, Here's Why appeared first on Penny Stocks to Buy, Picks, News and Infor

Which penny stocks are the best for your watchlist in 2021? The post Best 3 Penny Stocks to Watch Right Now, Worth it or Not?

Los Angeles, California--(Newsfile Corp. - June 18, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Akeb

CAMBRIDGE, Mass., June 3, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today